acetylcysteine has been researched along with Hormone-Dependent Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, S; Huang, W; Huang, X; Huang, Y; Li, Y; Pei, C; Pu, H; Wan, X; Wu, H; Yang, S; Zhang, C; Zhang, J; Zhang, Y | 1 |
| Ehrlich, M; Pinkas-Kramarski, R; Schmukler, E; Shai, B | 1 |
| Bershteĭn, LM; Boiarkina, MP; Kisel'nikov, KS; Kovalenko, IG; Poroshina, TE; Vasil'ev, DA; Zaĭtsev, AN | 1 |
3 other study(ies) available for acetylcysteine and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
KDM1A triggers androgen-induced miRNA transcription via H3K4me2 demethylation and DNA oxidation.
Topics: Acetylcysteine; Cell Line, Tumor; DNA, Neoplasm; Histone Demethylases; Histones; Humans; Kallikreins; Male; MicroRNAs; Neoplasms, Hormone-Dependent; Oxidation-Reduction; Pargyline; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Small Interfering; Serine Endopeptidases; Transcription, Genetic | 2015 |
Neuregulin promotes incomplete autophagy of prostate cancer cells that is independent of mTOR pathway inhibition.
Topics: Acetylcysteine; Adenine; Anthracenes; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cell Death; Cell Line, Tumor; Humans; Male; MAP Kinase Signaling System; Membrane Proteins; Neoplasms, Hormone-Dependent; Neuregulins; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Recombinant Proteins; Signal Transduction; TOR Serine-Threonine Kinases | 2012 |
[The influence of metformin and N-acetylcysteine on mammographic density in postmenopausal women].
Topics: Acetylcysteine; Aged; Apoptosis; Breast; Breast Neoplasms; Cell Proliferation; DNA Repair; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Mammography; Metformin; Middle Aged; Neoplasms, Hormone-Dependent; Postmenopause; Risk Assessment; Risk Factors | 2012 |